Enzalutamide 40 mg Capsule

Product Description

Enzaptor 40mg Capsule contains the active compound enzalutamide which belongs to the class of medications called androgen receptor inhibitors. It is used to treat men with prostate cancer. It is suitable for treatment in men with high testosterone, where the treatments (hormonal therapy or testosterone-lowering surgery) that reduce testosterone no longer totally cure the malignancy. It is also suitable for treatment in metastatic cases where the cancer has spread from the prostate to other parts and reacts to hormone therapy or surgery to reduce testosterone levels. It is also used in cases of Prostate cancer that is responsive to castration( surgical removal of testicles) but is not metastatic, with a high chance of metastasis and a biochemical recurrence.

It is not recommended to take Enzaptor 40mg Capsule if you are allergic to active compounds or any other ingredients of this medicine. It is not recommended for use in children and adolescents below the age of 18. Men are advised to use effective contraceptive methods during the therapy and 3 months after the treatment since it has the ability to harm the developing foetus. Inform your doctor if you are pregnant or planning to get pregnant to know about effective contraceptive methods. It is recommended to test your bone density during the treatment. 

Before initiating the treatment, inform your physician if you have any infections, kidney, heart or liver problems. Patients who have ischemic heart disease are closely monitored for risk factors.  Inform your doctor right away if you experience a seizure, headache that is getting worse, disorientation, blindness, or any other vision issues. It is necessary to inform your physician about all the medicines, over the counter drugs, vitamin and herbal supplements you are taking before the start of therapy. 

Uses of Enzaptor 40mg Capsule

• Prostate cancer resistant to other treatments
• Metastatic prostate cancer reacts to hormone therapy or surgery to reduce testosterone levels
• Non metastatic prostate cancer with a high chance of spread and recurrence.